Advertisement

Topics

Chugai Pharmaceutical Co., Ltd Company Profile

19:25 EST 23rd November 2017 | BioPortfolio

Chugai Pharmaceutical Co., Ltd. places tremendous importance on the safekeeping of personal information obtained from customers using our website (information that is personally identifiable such as your name, address, e-mail address, or phone number, and that is not otherwise publicly available). Based on our Privacy Policy the following regulations have been implemented to insure that this information is strictly safeguarded and that the utmost care is given to the handling of the information.

Contact

Email: pr@chugai-pharm.co.jp


News Articles [322 Associated News Articles listed on BioPortfolio]

Arbitration against Chugai commenced

Japanese drug major Chugai Pharmaceutical today announced that an arbitration against Chugai has been…

Chugai files lawsuit to protect its Herceptin

Japan’s Chugai Pharmaceutical saw its shares gain 2.15% to 4,515 yen, after it revealed legislation…

Chugai sheds older products to focus on innovation

Japan’s Chugai Pharmaceutical is to sell 13 so-called long-listed products - branded drugs that are…

HEMLIBRA von Chugai erhält von FDA weltweit erste behördliche Zulassung für Hämophilie A

Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) hat heute bekanntgegeben, dass die US-amerikanische Food and Drug Administration (FDA) den bispezifischen Antikörper Emicizumab (Produktname in den USA...

Chugai's HEMLIBRA Receives the World's First Regulatory Approval from FDA for Hemophilia A with Inhibitors

Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced today that the U.S. Food and Drug Administration (FDA) has approved the bispecific antibody emicizumab (US product name: HEMLIBRA) for routin...

US FDA grants priority review status to Chugai's BLA for emicizumab to treat hemophilia A with inhibitors

Chugai Pharmaceutical announced that the US Food and Drugs Administration (FDA) has accepted the Biologics License Application (BLA) and has granted Priority Review for an investigational antibody emi...

Chugai’s Bispecific Antibody “ERY974” Results of Preclinical Study Published in Science Translational Medicine

– Chugai’s Research Findings Adopted by World-Class Academic Journal – TOKYO–(BUSINESS WIRE)–#antibody—Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced today...

Chugai Pharmaceutical Co., Ltd. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 19102017] Prices from USD $350

Chugai Pharmaceutical Co., Ltd. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Chugai Pharmaceutical Co., Ltd. Mergers Acquisitions MA, Partnerships Alli...

PubMed Articles [400 Associated PubMed Articles listed on BioPortfolio]

Successful ablation of plunging ranula by ultrasound-guided percutaneous ethanol injection.

Evidence supporting any one treatment for plunging ranula is limited. Standard treatment-complete excision of the sublingual gland and ranula-is invasive and morbid given the close operative proximity...

Pharmaceutical care for patients of the third age in pharmacy organizations as a significant aspect of social gerontology.

There are questions in the article that study mutual relations of patients of elderly and senile age with pharmaceutical experts. It was revealed that pharmacy organizations are an important element i...

Critical review of surface-enhanced Raman spectroscopy applications in the pharmaceutical field.

Surface-enhanced Raman spectroscopy (SERS) is a sensitive analytical tool used in the pharmaceutical field in recent years. SERS keeps all the advantages of classical Raman spectroscopy while being is...

Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding.

Chapter issued by the United States Pharmacopeial Convention, Inc. is the standard for sterile compounding. It is designed to reduce the number of patient infections due to contaminated pharmaceutica...

Patent trend and competitive analysis of cancer immunotherapy in the United States.

Immunotherapy has brought high hopes for cancer treatment, and attracted tremendous resources from the biopharmaceutical community. Here we analyze cancer immunotherapy-related patents granted by the ...

Clinical Trials [272 Associated Clinical Trials listed on BioPortfolio]

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...

Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older

The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...

Pharmaceutical Care Service in Diabetes

The purpose of this study is to examine the effectiveness of pharmaceutical care service in the management of poorly controlled type 2 diabetes mellitus.

Companies [1017 Associated Companies listed on BioPortfolio]

Chugai Pharma Europe Ltd

Chugai Pharmaceutical Co., Ltd is headquartered in Tokyo, Japan. In its home market, Chugai is a household name, with a broad-ranging product portfolio encompassing highly specialised therapeutic anti...

Chugai Pharma Europe Limited

European headquarters of Chugai Pharmaceutical Co. Ltd. and Chugai Pharma UK Ltd.

Chugai Pharmaceutical Co., Ltd

Chugai Pharmaceutical Co., Ltd. places tremendous importance on the safekeeping of personal information obtained from customers using our website (information that is personally identifiable such as y...

Chugai Pharmaceutical Co., Ltd.

Chugai Pharmaceutical Company Limited

BioHealthcare Oncology

More Information about "Chugai Pharmaceutical Co., Ltd" on BioPortfolio

We have published hundreds of Chugai Pharmaceutical Co., Ltd news stories on BioPortfolio along with dozens of Chugai Pharmaceutical Co., Ltd Clinical Trials and PubMed Articles about Chugai Pharmaceutical Co., Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chugai Pharmaceutical Co., Ltd Companies in our database. You can also find out about relevant Chugai Pharmaceutical Co., Ltd Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record